Cargando…

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial

BACKGROUND: The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic features in patients with non-alcoholic fatty liver disease (NAFLD). METHODS: Fifty patients with NAFLD were randomized to receive lifestyle modification advice plus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saadati, Saeede, Sadeghi, Amir, Mansour, Asieh, Yari, Zahra, Poustchi, Hossein, Hedayati, Mehdi, Hatami, Behzad, Hekmatdoost, Azita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659284/ https://www.ncbi.nlm.nih.gov/pubmed/31345163 http://dx.doi.org/10.1186/s12876-019-1055-4

Ejemplares similares

Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

Dietary total antioxidant capacity is inversely associated with the odds of non-alcoholic fatty liver disease in people with type-2 diabetes
por: Salavatizadeh, Marieh, et al.
Publicado: (2022)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

Short term effects of coffee components consumption on gut microbiota in patients with non-alcoholic fatty liver and diabetes: A pilot randomized placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2020)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2021)

Dietary fiber intake and risk of gallstone: a case–control study
por: Tehrani, Asal Neshatbini, et al.
Publicado: (2023)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
por: Salavatizadeh, Marieh, et al.
Publicado: (2023)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Rahimlou, Mehran, et al.
Publicado: (2016)

Dietary Total Antioxidant Capacity and Risk of Gall Stone: A Case-Control Study
por: Saadati, Saeede, et al.
Publicado: (2021)

Effects of Vitamin D Supplementation in Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2019)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

Dietary inflammatory index and risk of gallstone disease in Iranian women: a case-control study
por: Ghorbani, Moloud, et al.
Publicado: (2023)

Salt consumption and mortality risk in cirrhotic patients: results from a cohort study
por: Pashayee-Khamene, Fereshteh, et al.
Publicado: (2022)

Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
por: Mansour, Asieh, et al.
Publicado: (2023)

The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status
por: Karimi, Sara, et al.
Publicado: (2019)

Combination therapy of flaxseed and hesperidin enhances the effectiveness of lifestyle modification in cardiovascular risk control in prediabetes: a randomized controlled trial
por: Yari, Zahra, et al.
Publicado: (2021)

Evaluation of the cardiovascular risk in patients with biliary stones: a descriptive cross-sectional study
por: Seddighi, Shermin, et al.
Publicado: (2018)

Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study
por: Ghamarzad Shishavan, Neda, et al.
Publicado: (2021)

Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case–control study in Iran
por: Yari, Zahra, et al.
Publicado: (2020)

Correction to: Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case–control study in Iran
por: Yari, Zahra, et al.
Publicado: (2020)

The effects of rice bran supplementation for management of blood lipids: A GRADE-assessed systematic review, dose–response meta-analysis, and meta-regression of randomized controlled trials
por: Hariri, Zahra, et al.
Publicado: (2023)

Healthy Dietary Pattern Reduces Risk of Gallstones: Results of a Case-Control Study in Iran
por: Naseri, Kaveh, et al.
Publicado: (2022)

Systematic review of zinc biochemical indicators and risk of coronary heart disease
por: Hashemian, Maryam, et al.
Publicado: (2015)

Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
por: Karami, Sara, et al.
Publicado: (2021)

Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study
por: Daftari, Ghazal, et al.
Publicado: (2023)

Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease
por: Sarmadi, Negar, et al.
Publicado: (2022)

Dietary patterns and the risk of colorectal cancer and adenoma: a case control study in Iran
por: Bahrami, Alireza, et al.
Publicado: (2019)

Methyltetrahydrofolate vs Folic Acid Supplementation in Idiopathic Recurrent Miscarriage with Respect to Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms: A Randomized Controlled Trial
por: Hekmatdoost, Azita, et al.
Publicado: (2015)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Anti-Hyperglycemic and Insulin Sensitizer Effects of Turmeric and Its Principle Constituent Curcumin
por: Ghorbani, Zeinab, et al.
Publicado: (2014)

Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
por: Yari, Fatemeh Ali, et al.
Publicado: (2021)

Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial
por: Jalili, Mahsa, et al.
Publicado: (2015)

The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study
por: Asbaghi, Omid, et al.
Publicado: (2020)

Adherence to oxidative balance scores and lower odds of non-alcoholic fatty liver disease: a case–control study
por: Sohouli, Mohammad Hassan, et al.
Publicado: (2023)

Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism
por: Emamat, Hadi, et al.
Publicado: (2020)

Dietary fiber intake and mortality among survivors of liver cirrhosis: A prospective cohort study
por: Hariri, Zahra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0hsm7ks5jvrshdqb9l53smm8p9